Cardiac resynchronization therapy for prevention of heart failure events in elderly patients with left ventricular dysfunction

References

• Roger VL, Go AS, Lloyd-Jones DM et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation 123(4), e18–e209 (2011).
   PubMed Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G et al.; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 29(19), 2388–2442 (2008).
   PubMed Web of Science ®Google Scholar
• Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292(3), 344–350 (2004).
   PubMed Web of Science ®Google Scholar
• Levy D, Kenchaiah S, Larson MG et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347(18), 1397–1402 (2002).
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E et al.; Cardiac Resynchronization–Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352(15), 1539–1549 (2005).
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J et al.; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350(21), 2140–2150 (2004).
   PubMed Web of Science ®Google Scholar
• Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J. Am. Coll. Cardiol. 52(23), 1834–1843 (2008).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS et al.; MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 361(14), 1329–1338 (2009).
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 125(1), e2–e220 (2012).
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Lin F, Vittinghoff E et al. Predictors of heart failure among women with coronary disease. Circulation 110(11), 1424–1430 (2004).
   PubMedGoogle Scholar
• Kannel WB. Incidence and epidemiology of heart failure. Heart Fail. Rev. 5(2), 167–173 (2000).
   PubMedGoogle Scholar
• Kupari M, Lindroos M, Iivanainen AM, Heikkilä J, Tilvis R. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J. Intern. Med. 241(5), 387–394 (1997).
   PubMed Web of Science ®Google Scholar
• Oxenham H, Sharpe N. Cardiovascular aging and heart failure. Eur. J. Heart Fail. 5(4), 427–434 (2003).
   PubMed Web of Science ®Google Scholar
• Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ. Res. 68(6), 1560–1568 (1991).
   PubMed Web of Science ®Google Scholar
• Komajda M, Hanon O, Hochadel M et al. Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I. Eur. Heart J. 28(11), 1310–1318 (2007).
   PubMedGoogle Scholar
• Komajda M, Hanon O, Hochadel M et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur. Heart J. 30(4), 478–486 (2009).
   PubMedGoogle Scholar
• Goldenberg I, Moss AJ, McNitt S et al.; Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy Investigators. Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT). Heart Rhythm 7(12), 1777–1782 (2010).
   PubMedGoogle Scholar
• House AA, Anand I, Bellomo R et al.; Acute Dialysis Quality Initiative Consensus Group. Definition and classification of cardio–renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol. Dial. Transplant. 25(5), 1416–1420 (2010).
   PubMed Web of Science ®Google Scholar
• Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 52(19), 1527–1539 (2008).
   PubMed Web of Science ®Google Scholar
• Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 35(3), 681–689 (2000).
   PubMed Web of Science ®Google Scholar
• Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke 37(8), 1969–1974 (2006).
   PubMed Web of Science ®Google Scholar
• Trojano L, Antonelli Incalzi R, Acanfora D, Picone C, Mecocci P, Rengo F; Congestive Heart Failure Italian Study Investigators. Cognitive impairment: a key feature of congestive heart failure in the elderly. J. Neurol. 250(12), 1456–1463 (2003).
   PubMedGoogle Scholar
• Heckman GA, Patterson CJ, Demers C, St Onge J, Turpie ID, McKelvie RS. Heart failure and cognitive impairment: challenges and opportunities. Clin. Interv. Aging 2(2), 209–218 (2007).
   PubMed Web of Science ®Google Scholar
• Flather MD, Shibata MC, Coats AJ et al.; SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur. Heart J. 26(3), 215–225 (2005).
   PubMed Web of Science ®Google Scholar
• Flather MD, Yusuf S, Køber L et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 355(9215), 1575–1581 (2000).
   PubMed Web of Science ®Google Scholar
• Lenzen MJ, Boersma E, Reimer WJ et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur. Heart J. 26(24), 2706–2713 (2005).
   PubMedGoogle Scholar
• Lindenfeld J, Albert NM, Boehmer JP et al.; Heart Failure Society of America. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J. Card. Fail. 16(6), e1–e194 (2010).
   Web of Science ®Google Scholar
• Jessup M, Abraham WT, Casey DE et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14), 1977–2016 (2009).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med. 335(26), 1933–1940 (1996).
   PubMed Web of Science ®Google Scholar
• Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med. 341(25), 1882–1890 (1999).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Zareba W, Hall WJ et al.; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346(12), 877–883 (2002).
   PubMed Web of Science ®Google Scholar
• Kadish A, Dyer A, Daubert JP et al.; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med. 350(21), 2151–2158 (2004).
   PubMed Web of Science ®Google Scholar
• Bardy GH, Lee KL, Mark DB et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N. Engl. J. Med. 352(3), 225–237 (2005).
   PubMed Web of Science ®Google Scholar
• Huang DT, Sesselberg HW, McNitt S et al.; MADIT-II Research Group. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J. Cardiovasc. Electrophysiol. 18(8), 833–838 (2007).
   PubMedGoogle Scholar
• Goldenberg I, Moss AJ. Treatment of arrhythmias and use of implantable cardioverter–defibrillators to improve survival in elderly patients with cardiac disease. Clin. Geriatr. Med. 23(1), 205–219 (2007).
   PubMedGoogle Scholar
• Santangeli P, Di Biase L, Dello Russo A et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann. Intern. Med. 153(9), 592–599 (2010).
   PubMed Web of Science ®Google Scholar
• Hohnloser SH, Kuck KH, Dorian P et al.; DINAMIT Investigators. Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction. N. Engl. J. Med. 351(24), 2481–2488 (2004).
   PubMed Web of Science ®Google Scholar
• Steinbeck G, Andresen D, Seidl K et al.; IRIS Investigators. Defibrillator implantation early after myocardial infarction. N. Engl. J. Med. 361(15), 1427–1436 (2009).
   PubMed Web of Science ®Google Scholar
• Kong MH, Al-Khatib SM, Sanders GD, Hasselblad V, Peterson ED. Use of implantable cardioverter–defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis. Cardiol. J. 18(5), 503–514 (2011).
   PubMedGoogle Scholar
• Kron J, Aranda JM Jr, Miles WM et al. Benefit of cardiac resynchronization in elderly patients: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. J. Interv. Card. Electrophysiol. 25(2), 91–96 (2009).
   PubMedGoogle Scholar
• Delnoy PP, Ottervanger JP, Luttikhuis HO et al. Clinical response of cardiac resynchronization therapy in the elderly. Am. Heart J. 155(4), 746–751 (2008).
   PubMed Web of Science ®Google Scholar
• Achilli A, Turreni F, Gasparini M et al. Efficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry. Europace 9(9), 732–738 (2007).
   PubMedGoogle Scholar
• Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch. Intern. Med. 162(15), 1689–1694 (2002).
   PubMed Web of Science ®Google Scholar
• Cowie MR, Mosterd A, Wood DA et al. The epidemiology of heart failure. Eur. Heart J. 18(2), 208–225 (1997).
   PubMed Web of Science ®Google Scholar
• Tang AS, Wells GA, Talajic M et al.; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med. 363(25), 2385–2395 (2010).
   PubMed Web of Science ®Google Scholar
• St John Sutton M, Ghio S, Plappert T et al.; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure. Circulation 120(19), 1858–1865 (2009).
   PubMed Web of Science ®Google Scholar
• Penn J, Goldenberg I, Moss AJ et al.; MADIT-CRT Trial investigators. Improved outcome with preventive cardiac resynchronization therapy in the elderly: a MADIT-CRT substudy. J. Cardiovasc. Electrophysiol. 22(8), 892–897 (2011).
   PubMedGoogle Scholar
• Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA; National Cardiovascular Data’s ICD Registry. Influence of age on perioperative complications among patients undergoing implantable cardioverter–defibrillators for primary prevention in the United States. Circ. Cardiovasc. Qual. Outcomes 4(5), 549–556 (2011).
   PubMedGoogle Scholar
• Tracy CM, Epstein AE, Darbar D et al. 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 126(14), 1784–1800 (2012).
   PubMed Web of Science ®Google Scholar
• Dickstein K, Vardas PE, Auricchio A et al.; Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur. Heart J. 31(21), 2677–2687 (2010).
   PubMed Web of Science ®Google Scholar